Publikationen
225.
Weert LTCM,
Buurstede JC,
Sips HCM,
Vettorazzi S,
Mol IM,
Hartmann J,
Prekovic S,
Zwart W,
Schmidt MV,
Roozendaal B,
Tuckermann JP,
Sarabdjitsingh RA,
Meijer OC.
Identification of mineralocorticoid receptor target genes in the mouse hippocampus.
Journal of neuroendocrinology.
2019;
31(8):e12735.
[DOI]
224.
Weert LTCM,
Buurstede JC,
Sips HCM,
Vettorazzi S,
Mol IM,
Hartmann J,
Prekovic S,
Zwart W,
Schmidt MV,
Roozendaal B,
Tuckermann JP,
Sarabdjitsingh RA,
Meijer OC.
Identification of mineralocorticoid receptor target genes in the mouse hippocampus.
Journal of neuroendocrinology.
2019;
31(8):e12735.
[DOI]
223.
Weert LTCM,
Buurstede JC,
Sips HCM,
Vettorazzi S,
Mol IM,
Hartmann J,
Prekovic S,
Zwart W,
Schmidt MV,
Roozendaal B,
Tuckermann JP,
Sarabdjitsingh RA,
Meijer OC.
Identification of mineralocorticoid receptor target genes in the mouse hippocampus.
Journal of neuroendocrinology.
2019;
31(8):e12735.
[DOI]
221.
Wepler M,
Preuss JM,
Merz T,
Hartmann C,
Wachter U,
McCook O,
Vogt J,
Kress S,
Gröger M,
Fink M,
Scheuerle A,
Möller P,
Calzia E,
Burret U,
Radermacher P,
Vettorazzi S.
Impaired Glucocorticoid Receptor Dimerization Aggravates LPS-Induced Circulatory and Pulmonary Dysfunction.
Front Immunol.
2019;
103152.
[DOI]
[Datei]
220.
Wepler M,
Preuss JM,
Merz T,
Hartmann C,
Wachter U,
McCook O,
Vogt J,
Kress S,
Gröger M,
Fink M,
Scheuerle A,
Möller P,
Calzia E,
Burret U,
Radermacher P,
Tuckermann JP,
Vettorazzi S.
Impaired Glucocorticoid Receptor Dimerization Aggravates LPS-Induced Circulatory and Pulmonary Dysfunction.
Frontiers in immunology.
2019;
103152.
[DOI]
219.
Wepler M,
Preuss JM,
Merz T,
Hartmann C,
Wachter U,
McCook O,
Vogt J,
Kress S,
Gröger M,
Fink M,
Scheuerle A,
Möller P,
Calzia E,
Burret U,
Radermacher P,
Tuckermann JP,
Vettorazzi S.
Impaired Glucocorticoid Receptor Dimerization Aggravates LPS-Induced Circulatory and Pulmonary Dysfunction.
Frontiers in immunology.
2019;
103152.
[DOI]
218.
Wepler M,
Preuss JM,
Merz T,
Hartmann C,
Wachter U,
McCook O,
Vogt J,
Kress S,
Gröger M,
Fink M,
Scheuerle A,
Möller P,
Calzia E,
Burret U,
Radermacher P,
Tuckermann JP,
Vettorazzi S.
Impaired Glucocorticoid Receptor Dimerization Aggravates LPS-Induced Circulatory and Pulmonary Dysfunction.
Frontiers in immunology.
2019;
103152.
[DOI]
217.
Javaheri T,
Kazemi Z,
Pencik J,
Pham HTT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DNT,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell death & disease.
2019;
10(8):605.
[DOI]
216.
Javaheri T,
Kazemi Z,
Pencik J,
Pham HTT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DNT,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell death & disease.
2019;
10(8):605.
[DOI]
215.
Javaheri T,
Kazemi Z,
Pencik J,
Pham HTT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DNT,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell death & disease.
2019;
10(8):605.
[DOI]
211.
Javaheri T,
Kazemi Z,
Jan P,
Pham HTT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DNT,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell death & disease.
2018;
9(8):800.
[DOI]
210.
Javaheri T,
Kazemi Z,
Jan P,
Pham HTT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DNT,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell death & disease.
2018;
9(8):800.
[DOI]
209.
Javaheri T,
Kazemi Z,
Jan P,
Pham HTT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DNT,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell death & disease.
2018;
9(8):800.
[DOI]
208.
Lee S,
Liu P,
Teinturier R,
Jakob J,
Tschaffon M,
Tasdogan A,
Wittig R,
Hoeller S,
Baumhoer D,
Frappart L,
Vettorazzi S,
Bertolino P,
Zhang C,
Tuckermann J.
Deletion of Menin in craniofacial osteogenic cells in mice elicits development of mandibular ossifying fibroma.
Oncogene.
2018;
37(5):616—626.
[DOI]
207.
Lee S,
Liu P,
Teinturier R,
Jakob J,
Tschaffon M,
Tasdogan A,
Wittig R,
Hoeller S,
Baumhoer D,
Frappart L,
Vettorazzi S,
Bertolino P,
Zhang C,
Tuckermann J.
Deletion of Menin in craniofacial osteogenic cells in mice elicits development of mandibular ossifying fibroma.
Oncogene.
2018;
37(5):616-626.
[DOI]
[Datei]
206.
Lee S,
Liu P,
Teinturier R,
Jakob J,
Tschaffon M,
Tasdogan A,
Wittig R,
Hoeller S,
Baumhoer D,
Frappart L,
Vettorazzi S,
Bertolino P,
Zhang C,
Tuckermann J.
Deletion of Menin in craniofacial osteogenic cells in mice elicits development of mandibular ossifying fibroma.
Oncogene.
2018;
37(5):616—626.
[DOI]
204.
Mueller KM,
Hartmann K,
Kaltenecker D,
Vettorazzi S,
Bauer M,
Mauser L,
Amann S,
Jall S,
Fischer K,
Esterbauer H,
Müller TD,
Tschöp MH,
Magnes C,
Haybaeck J,
Scherer T,
Bordag N,
Tuckermann JP,
Moriggl R.
Erratum. Adipocyte Glucocorticoid Receptor Deficiency Attenuates Aging- and HFD-Induced Obesity and Impairs the Feeding-Fasting Transition. Diabetes 2017;66:272-286.
Diabetes.
2018;
67(2):343—344.
[DOI]
203.
Mueller KM,
Hartmann K,
Kaltenecker D,
Vettorazzi S,
Bauer M,
Mauser L,
Amann S,
Jall S,
Fischer K,
Esterbauer H,
Müller TD,
Tschöp MH,
Magnes C,
Haybaeck J,
Scherer T,
Bordag N,
Tuckermann JP,
Moriggl R.
Erratum. Adipocyte Glucocorticoid Receptor Deficiency Attenuates Aging- and HFD-Induced Obesity and Impairs the Feeding-Fasting Transition. Diabetes 2017;66:272-286.
Diabetes.
2018;
67(2):343—344.
[DOI]
202.
Mueller KM,
Hartmann K,
Kaltenecker D,
Vettorazzi S,
Bauer M,
Mauser L,
Amann S,
Jall S,
Fischer K,
Esterbauer H,
Müller TD,
Tschöp MH,
Magnes C,
Haybaeck J,
Scherer T,
Bordag N,
Tuckermann JP,
Moriggl R.
Erratum. Adipocyte Glucocorticoid Receptor Deficiency Attenuates Aging- and HFD-Induced Obesity and Impairs the Feeding-Fasting Transition. Diabetes 2017;66:272-286.
Diabetes.
2018;
67(2):343—344.
[DOI]